- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07330960
Augmenting Existing Normative Data for QbMobile in Healthy Children Aged 6-11 Years
Augmenting Existing Normative Data for QbMobile in Healthy Children Aged 6-11 Years.
Study Overview
Status
Conditions
Detailed Description
Participants will be recruited and referred from selected clinics' general population databases, local schools, youth centers and organizations, as well as other general practitioners within the surrounding area.
Participants will be pre-screened via an online questionnaire completed by their parent/legal guardian designed to capture diagnostic history and general demographic information. Access to the questionnaire will be initiated by scanning a QR code on the study flyer that will be visibly posted at locations listed above.
Parents or legal guardians will be asked to provide a reliable phone number within the pre-screening questionnaire, which will be used by the research team to follow up and verify the information submitted in the questionnaire. Once eligibility is confirmed through both the questionnaire and phone verification, participants will be scheduled for enrollment in the study.
On the scheduled study day, participants will complete a 10-minute QbMobile test.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Robert Nolen
- Phone Number: 18325370300
- Email: robert.nolen@qbtech.com
Study Contact Backup
- Name: Ragini Sanyal
- Email: ragini.sanyal@qbtech.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Provide informed consent from parent/legal guardians and assent for all study participants for the QbMobile study;
- Aged > 6 years and < 11 years old;
- Have no documented or suspected current or lifetime diagnosis of ADHD;
- Have adequate sensory and physical ability to complete QbMobile;
Exclusion Criteria:
- Intellectual disability designated by IQ<75;
- Has a concurrent medical diagnosis that could significantly affect test performance such as brain injuries, Parkinson's disease, current epilepsy or active seizures, amyotrophic lateral sclerosis (ALS), multiple sclerosis, dementias (e.g. vascular dementia, Alzheimer disease), unmanaged psychiatric illness;
- Has other conditions that could affect test performance (migraine or other types of severe headache, chronic or acute pain);
- Substance use (e.g., alcohol, drugs) that may affect performance on the day of the tests.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthy Volunteers
|
Participants will complete a non-invasive, 10-minute digital tests using the QbMobile Investigational Device.
The test objectively measure cognitive performance and activity levels.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Establishment of Normative Statistics for QbMobile Performance
Time Frame: 1 QbMobile test at the clinic visit (Day 1)
|
Normative data will be analyzed to generate Standard Deviation (SD) scores and Total Scores for four domains: activity, impulsivity, inattention, and movement patterns.
QbMobile SD-scores are standardized metrics derived from the main parameters (attention, impulsivity, activity and movement).
These scores are calculated using and age and sex at birth adjusted normative dataset.
The QbMobile also produces a Total Score number ranging from 0 to 100, where 0 indicates a low likelihood of exhibiting ADHD symptoms and 100 indicates a high likelihood of exhibiting ADHD symptoms.
These scores will enable individual test performance to be expressed relative to normative benchmarks.
|
1 QbMobile test at the clinic visit (Day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exploratory Analysis of Additional Domain Parameters
Time Frame: 1 QbMobile test at the clinic visit (Day 1)
|
Exploratory analyses will be conducted on raw QbMobile data collected at Day 1 to identify potential additional parameters that may serve as indices of activity, attention, impulsivity, and movement from the QbMobile Standard Deviation (SD) Scores and Total Scores.
QbMobile SD-scores are standardized metrics derived from the main parameters (attention, impulsivity, activity and movement).
These scores are calculated using and age and sex at birth adjusted normative dataset.
The QbMobile also produces a Total Score number ranging from 0 to 100, where 0 indicates a low likelihood of exhibiting ADHD symptoms and 100 indicates a high likelihood of exhibiting ADHD symptoms.
These parameters will be evaluated for their potential association with ADHD symptomatology.
|
1 QbMobile test at the clinic visit (Day 1)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 00091260 QB25-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteer
-
University Magna GraeciaNot yet recruitingHealthy Volunteer | Healthy Volunteer StudyItaly
-
National Heart, Lung, and Blood Institute (NHLBI)TerminatedHealthy | Healthy Volunteer | HVUnited States
-
Hospices Civils de LyonNot yet recruiting
-
AbbVieNot yet recruiting
-
TrueLab Biopharmaceutical Co., LtdSAPRO Consulting Pty LtdRecruiting
-
Aspargo Labs, IncNot yet recruitingHealthy Volunteer
-
Aspargo Labs, IncNot yet recruiting
-
Aspargo Labs, IncNot yet recruiting
-
AbbVieRecruitingHealthy VolunteerUnited States
-
Johns Hopkins UniversityRecruitingHealthy VolunteerUnited States
Clinical Trials on Digital software application for cognitive performance and activity measurement (QbMobile, investigational device)
-
Qbtech ABRecruitingSocial Anxiety Disorder | Separation Anxiety Disorder | Autism Spectrum Disorder (ASD) | Bi-Polar Disorder | Generalized Anxiety Disorder (GAD) | Major Depression DisordersUnited States
-
Andreia LoboUniversity of Beira Interior; Centro Hospitalar Universitário de CoimbraCompletedMetabolic Syndrome (MetS)Portugal
-
Washington University School of MedicineEdward P. Evans FoundationRecruitingCardiovascular Diseases | Aged | Geriatrics | Geriatric SyndromesUnited States